Carlos Milla

Autonomous sweat extraction and analysis applied to cystic fibrosis and glucose monitoring using a fully integrated wearable platform

Sam Emaminejad, Wei Gao, Eric Wu et al. · Proceedings of the National Academy of Sciences · 2017 · 788 citations · Full text

Repeated Adeno-Associated Virus Serotype 2 Aerosol-Mediated Cystic Fibrosis Transmembrane Regulator Gene Transfer to the Lungs of Patients With Cystic Fibrosis

Richard B. Moss, David M. Rodman, L. Terry Spencer et al. · CHEST Journal · 2004 · 383 citations

Pathogenesis, Pathology, Respiratory Infection +4

Trends in Pulmonary Function in Patients with Cystic Fibrosis Correlate with the Degree of Glucose Intolerance at Baseline

Carlos Milla, Warren J. Warwick, Antoinette Moran · American Journal of Respiratory and Critical Care Medicine · 2000 · 358 citations

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 291 citations

Pulmonary Fibrosis, Medicine, Placebo-controlled Phase 3

Repeated Aerosolized AAV-CFTR for Treatment of Cystic Fibrosis: A Randomized Placebo-Controlled Phase 2B Trial

Richard B. Moss, Carlos Milla, John L. Colombo et al. · Human Gene Therapy · 2007 · 267 citations